Ann: New USCOM 1A digital connectivity feature released, page-3

The only thing that will move this stock is finally getting FDA approval for all their products. The delays in approval and lack of explanation from the company re the need for additional software and the timetables for development of same has been poor and Rob would have been better off being upfront and doing a bit less of the cut and paste graphs. This is all coming together about a year after we were led to believe it would.

Having said that though it now looks as if the issues holding same up have been addressed , FDA approval should be forthcoming and with the Chinese agreement they are in a much better position than when they were last at these prices.

But I feel bad about those who might have lost money on this stock on my previous ramping so DYOR.